Efficacy and Safety of Navarixin (SCH 527123) in Participants With Allergen-Induced Asthma (P05363)

NCT00688467 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Navarixin
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC